STOCK TITAN

Medigus Ltd. American Depositary Share Stock Price, News & Analysis

MDGS Nasdaq

Welcome to our dedicated page for Medigus Ltd. American Depositary Share news (Ticker: MDGS), a resource for investors and traders seeking the latest updates and insights on Medigus Ltd. American Depositary Share stock.

The MDGS news page on Stock Titan provides an organized view of announcements and disclosures related to the company historically associated with Medigus and, in more recent communications, with Xylo Technologies Ltd. Medigus is described as a medical device company in surgical and medical instrument manufacturing, focused on endoscopic systems for GERD treatment, while Xylo is presented in news releases as a technologies company engaged in advanced medical solutions, digital commerce, and electric vehicle markets through various affiliates.

News items connected to this lineage describe Xylo Technologies as based in Israel and traded on the Nasdaq Capital Market under the symbol XYLO. These releases highlight affiliations in advanced medical solutions via Polyrizon Ltd., in digital commerce via Gix Internet Ltd. and Eventer Technologies Ltd., and in electric vehicle technologies through Charging Robotics, Inc. and Revoltz Ltd. Other affiliations mentioned include ParaZero Technologies Ltd. and Zig Miami 54 LLC.

On this page, readers can review company-related news that may cover topics such as developments in advanced medical solutions, updates from affiliated digital advertising and digital commerce businesses, progress in electric vehicle wireless charging systems, micro-mobility vehicles for last-mile logistics, and drone safety technologies. Each article reflects how the broader group of affiliated companies is described as pursuing technology-based growth partnerships.

Investors and followers of MDGS can use this news feed to trace how the focus described for Medigus as a medical device manufacturer connects with later descriptions of Xylo Technologies’ wider technology portfolio. Regularly reviewing these items can help users understand how the company’s affiliations in medical, digital, and electric vehicle-related fields are presented in public communications.

Rhea-AI Summary

Xylo Technologies announces that Charging Robotics, a company it owns a 67% stake in, has received its first commercial order for its wireless EV charging systems from Parking Design. This order entails the deployment of 12 systems in automatic parking facilities, to be fulfilled throughout 2025. The wireless charging system uses AI and machine learning to optimize EV charging, ensuring efficient and prioritized energy distribution. This innovation aims to enhance the convenience and sustainability of automated parking solutions. A pilot project was recently completed in Tel Aviv, marking a significant milestone in their collaboration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) announced that its subsidiary Gix Internet (45.75% owned by Xylo, TASE: GIX) signed a non-binding MOU with a robotics company specializing in AI autonomous robotics for medical logistics. The MOU outlines a share exchange transaction, where the robotics company will become a wholly-owned subsidiary of Gix. The completion of this transaction is expected to provide Gix with growth opportunities and technological advancements in AI and robotics. Shareholders of the robotics company will receive 30% of Gix's ordinary shares, with options to increase holdings to 37.5% and 45% upon meeting specific commercial milestones.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.06%
Tags
-
Rhea-AI Summary

Xylo Technologies announced that its 19.99% owned subsidiary, Metagramm Software, completed the development of Bubbl, an advanced AI-powered writing tool. Bubbl employs Machine Learning, Natural Language Processing, and Deep Learning to offer personalized text writing and rewriting, setting it apart from other AI tools. The tool features a clean design and various user modes, including interactive re-write and grammar-only modes. It supports multiple writing profiles, such as Business, Medical, Academic, and Blogging, each with tailored assistance. Bubbl will launch for select users in Q3 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
AI
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) has signed a letter of intent (LOI) to acquire a leading AI technology company based in Germany. This acquisition aims to expand Xylo's portfolio into advanced AI technologies such as predictive maintenance and condition monitoring. The target company has been a European leader for over a decade, providing AI and machine learning solutions to various global industries including aerospace, aviation, transportation, real estate, and security. Xylo will make a down payment of 1.5 million Euros and initially acquire 51% of the target company's shares, with the remaining 49% contingent on the company's 2024 EBITDA results. This strategic move was facilitated by Xylo's newly appointed senior advisor, an expert in AI with a distinguished career in both academia and industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.9%
Tags
-
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) announced that Charging Robotics (OTC: FDOCD), 67% owned by Xylo, in collaboration with Make My Day, has reached the final development stage of an AI-based EV charging management system.

This system addresses the challenge of insufficient electricity supply for EV charging in automatic car parks by using machine learning algorithms to prioritize and optimize charging sequences based on parameters such as departure time, vehicle type, and driving style.

The system integrates seamlessly with Charging Robotics’ wireless charging setup and was recently piloted in Tel Aviv, Israel.

CEO Hovav Gilan emphasized the value this feature adds for future customers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.88%
Tags
AI
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.96%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.1%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
none

FAQ

What is the current stock price of Medigus Ltd. American Depositary Share (MDGS)?

The current stock price of Medigus Ltd. American Depositary Share (MDGS) is $2.36 as of January 17, 2024.

What is the market cap of Medigus Ltd. American Depositary Share (MDGS)?

The market cap of Medigus Ltd. American Depositary Share (MDGS) is approximately 4.5M.

MDGS Rankings

MDGS Stock Data

4.47M
28.42M
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Israel
Pob 3030

MDGS RSS Feed